During this study patients will receive treatment of omeprazole at the dose depending on group enrollment
Group A will receive omeprazole 80 mg, twice a day for 14 days unless unacceptable toxicity
Group B, will receive omeprazole 20 mg, once a day for 14 days
Patients will receive treatment for 2~3 weeks during the study, and 2 months of follow up.
Total accrual is anticipated to take 2 years.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.